Cargando…
Analysis of NAMCS data for multiple sclerosis, 1998–2004
BACKGROUND: To our knowledge, no study to date has investigated the prescribing patterns of immunomodulatory agents (IMAs) in an outpatient setting in the United States. To address this issue, we performed retrospective data analyses on National Ambulatory Medical Care Survey (NAMCS) data for MS pat...
Autores principales: | Avasarala, Jagannadha R, O'Donovan, Cormac A, Roach, Steve E, Camacho, Fabian, Feldman, Steven R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1855349/ https://www.ncbi.nlm.nih.gov/pubmed/17411425 http://dx.doi.org/10.1186/1741-7015-5-6 |
Ejemplares similares
-
Anti-CD20 Cell Therapies in Multiple Sclerosis—A Fixed Dosing Schedule for Ocrelizumab is Overkill
por: Avasarala, Jagannadha
Publicado: (2017) -
Can Aspirin Minimize Stroke Risk and New Lesion Formation in Multiple Sclerosis?
por: Avasarala, Jagannadha, et al.
Publicado: (2018) -
Management of Pediatric Psoriasis: A U.S. Survey Based on Visits from the National Ambulatory Medical Care Survey (NAMCS)
por: Tao, Rachel E., et al.
Publicado: (2023) -
A nomogram for predicting echocardiogram prescription in outpatients: an analysis of the NAMCS database
por: Liu, Yujian, et al.
Publicado: (2023) -
Memoria sexenal, 1998-2004
Publicado: (2004)